{"id":202185,"name":"CEPI-U.S.","slug":"cepi-us","state":"DC","country":"United States of America","description":"","totalSpending":1359000,"filings":40,"yearlySpending":[{"year":2018,"income":28000},{"year":2019,"income":28000},{"year":2020,"income":253000},{"year":2021,"income":160000},{"year":2022,"income":200000},{"year":2023,"income":220000},{"year":2024,"income":210000},{"year":2025,"income":260000}],"issues":["HCR","BUD","FOR"],"firms":["CEPI-U.S."],"lobbyists":["DAWN O'CONNELL","RICHARD HATCHETT","RICHARD WILDER","DANIEL SKALLMAN"],"govEntities":["Defense, Dept of (DOD)","HOUSE OF REPRESENTATIVES","Natl Security Council (NSC)","SENATE","U.S. Agency for International Development (USAID)","Office of Management & Budget (OMB)","Health & Human Services, Dept of (HHS)","White House Office","State, Dept of (DOS)","Overseas Private Investment Corp (OPIC)","Treasury, Dept of","Homeland Security, Dept of (DHS)","Food & Drug Administration (FDA)","Office of Science & Technology Policy (OSTP)","Natl Institutes of Health (NIH)","Centers For Disease Control & Prevention (CDC)"],"sampleDescriptions":["Appropriations for CEPI Norway, Pandemics and All-Hazards Preparedness Reauthorization.","Appropriations for CEPI Norway, Pandemics and All-Hazards Preparedness Reauthorization, possible addition of MERS/Lassa/Nipah to FDA's Priority Review Voucher program.","Appropriations for CEPI Norway, Pandemics and All-Hazards Preparedness Reauthorization, possible addition of MERS/Lassa/Nipah to FDA's Priority Review Voucher program.","Appropriations for CEPI Norway, Pandemics and All-Hazards Preparedness Reauthorization, possible addition of MERS//Nipah/Rift Valley Fever to FDA's Priority Review Voucher program.","Request for Member support of appropriations from USAID to CEPI.  Also support for a bill that will update Neglected Tropical Disease Priority Review Vouchers at FDA.  Being drafted (and soon introduc"],"years":[2018,2019,2020,2021,2022,2023,2024,2025]}